ERBB2 and ovarian carcinoma: To study whether miR-199a and miR-125b utilize these two pathways, ovarian cancer cells expressing vector alone, HER2, or HER3 were transfected with miR-199a and miR-125b precursor; and analyzed for AKT and ERK expression levels.